Re: Farmas USA
Sobre AMRN
"We believe that the company may be issuing a press release tonight or tomorrow to announce the US availability of Vascepa."
"Within the next few days, possibly as soon as this evening, AMRN will issue a press release announcing US availability of Vascepa"
"Depending on how the initial script numbers come in, AMRN stock will either begin a gradual recovery to the $10 - $12 range or drift lower to the $7 - $5 range over the next two months."